Business Organization, Intellectual Property, Health Law

Capital Infusion: Private Equity Update - May 2013

by Sean Clancy, Adam Connatser, Lindsay Faine, Jon Finger, Rani Hauth Guerra, J. Atwood Jeter, Robert Johnston III, Amy Kaufman, David McLean, Ryan Mitchell, George Schutzer, Akash Sethi | Patton Boggs LLP on 5/8/2013

In This Issue: - DIGGING DEEPER: A Guide to Health Care Regulatory Due Diligence in Private Equity Deals 1 - Policy Spotlight: Affordable Care Act 6 - Case Spotlight: Best Practices in Down-Round Financings &...more

Jennifer Abril on The Story of Fragrances [Video]

by LEVICK on 12/20/2012

In this LEVICK Daily video interview, we discuss the release of the new documentary The Story of Fragrances with Jennifer Abril, President of the International Fragrance Association North America. Not just perfumes and...more

Russia's Accession to the WTO: Benefits and Risks

by Armstrong Teasdale LLP on 8/29/2012

On August 22, 2012, the World Trade Organization welcomed Russia as its 156th member. As a result, Russia will lower its tariffs on imports of goods across all sectors of the economy and will reduce trade barriers. This will...more

Harvard Medical School Revises Conflicts of Interest Policy for Faculty Relationships with Industry

by William Fabbri on 9/30/2010

The life science industry has had a long and mutually rewarding relationship with Harvard Medical School (HMS). HMS faculty members have founded life science companies, served as advisors and directors to life science...more

Creative Royalty Structures for Life Science Companies

by William Fabbri on 5/12/2010

In any major license or partnering transaction, rarely is the royalty as simple as a single percentage on all net sales. The royalty provisions will include structures such as tier royalties, sublicense royalties, know-how...more

Joint Ownership: Shortcut to Trouble?

by William Fabbri on 2/17/2010

Life science companies are constantly entering into collaborations or other agreements with third parties in which new intellectual property may be created, whether it is a full-fledged partnership with a large pharmaceutical...more

Patent Opposition in India: Recent Trends

by Rahul Dev on 1/12/2010

Therefore, as may be seen, the two-stage patent opposition process has particularly affected the pharmaceutical industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or...more

Importance of Patents for Start-ups, specially in Biotech

by Rahul Dev on 1/8/2010

A patent is one of the ways by which technological innovations are protected. The most ironical fact about a patent is that although it gives monopoly for a number of years, but in order to gain the monopoly, the invention...more

Importance of Patents for Start-ups, specially in Biotech

by Rahul Dev on 1/8/2010

A patent is one of the ways by which technological innovations are protected. The most ironical fact about a patent is that although it gives monopoly for a number of years, but in order to gain the monopoly, the invention...more

Antitrust and Trade Regulation Briefing By Robert K. Taylor

by Partridge Snow & Hahn LLP on 3/1/2006

IN THIS ISSUE: *HIGHLIGHT ..U.S. Supreme Court Addresses Manufacturer Price Discrimination *RECENT DEVELOPMENTS ..Joint Venture Pricing Scrutinized ..Supreme Court Rules on Patent Tying ..Drug Companies Sued Over...more